NO20074313L - Preparater for kontrollert frigjoring omfattende et antipsykotisk middel - Google Patents

Preparater for kontrollert frigjoring omfattende et antipsykotisk middel

Info

Publication number
NO20074313L
NO20074313L NO20074313A NO20074313A NO20074313L NO 20074313 L NO20074313 L NO 20074313L NO 20074313 A NO20074313 A NO 20074313A NO 20074313 A NO20074313 A NO 20074313A NO 20074313 L NO20074313 L NO 20074313L
Authority
NO
Norway
Prior art keywords
antipsychotic
component
antipsychotic agent
subsequent
controlled release
Prior art date
Application number
NO20074313A
Other languages
English (en)
Norwegian (no)
Inventor
Gary Liversidge
Scott Jenkins
Original Assignee
Elan Pharma Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elan Pharma Int Ltd filed Critical Elan Pharma Int Ltd
Publication of NO20074313L publication Critical patent/NO20074313L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20074313A 2005-01-26 2007-08-23 Preparater for kontrollert frigjoring omfattende et antipsykotisk middel NO20074313L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64731105P 2005-01-26 2005-01-26
PCT/US2006/002751 WO2006081347A2 (en) 2005-01-26 2006-01-26 Controlled release compositions comprising an antipsychotic agent

Publications (1)

Publication Number Publication Date
NO20074313L true NO20074313L (no) 2007-10-17

Family

ID=36741043

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074313A NO20074313L (no) 2005-01-26 2007-08-23 Preparater for kontrollert frigjoring omfattende et antipsykotisk middel

Country Status (14)

Country Link
US (1) US20080268043A1 (pt)
EP (1) EP1846382A2 (pt)
JP (1) JP2008528607A (pt)
KR (1) KR20070102563A (pt)
CN (1) CN101124209A (pt)
AU (1) AU2006209212B2 (pt)
BR (1) BRPI0606932A2 (pt)
CA (1) CA2595885A1 (pt)
EA (1) EA200701591A1 (pt)
IL (1) IL184768A0 (pt)
MX (1) MX2007008985A (pt)
NO (1) NO20074313L (pt)
WO (1) WO2006081347A2 (pt)
ZA (1) ZA200706068B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265732B2 (en) 2006-03-06 2016-02-23 Pozen Inc. Dosage forms for administering combinations of drugs
EA020477B1 (ru) * 2008-11-26 2014-11-28 Крка, Товарна Здравил, Д. Д., Ново Место Композиция кветиапина
TR201008261A1 (tr) 2010-10-08 2012-04-24 Sanovel İlaç San. Ve Ti̇c. A.Ş. Kontrollü salım gerçekleştiren ketiapin formülasyonları
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1082206A (en) * 1963-07-02 1967-09-06 Applic Chimiques D Etudes & De Improved antibiotic medicine
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
US6586006B2 (en) * 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
JP4863534B2 (ja) * 1996-10-25 2012-01-25 スパーナス ファーマシューティカルズ インコーポレイテッド 可溶形態浸透用量送達システム
US6004582A (en) * 1997-05-30 1999-12-21 Laboratorios Phoenix U.S.A, Inc. Multi-layered osmotic device
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
DK1126826T6 (en) * 1998-11-02 2019-06-24 Alkermes Pharma Ireland Ltd Multiparticulate modified release of methylphenidate
BR9916361A (pt) * 1998-12-18 2002-11-05 Abbott Lab Forma de dosagem de tabletes de liberação controlada, formulação de tablete de liberação controlada, composição granular para prensagem em uma forma de dosagem de tablete de liberação controlada, e, métodos para preparar uma composição granular, para preparar uma forma de dosagem de tabletes de liberação controlada de divalproex sódio e para tratar epilepsia
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
US6572890B2 (en) * 2000-01-13 2003-06-03 Osmotica Corp. Osmotic device containing venlafaxine and an anti-psychotic agent
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
JP4643120B2 (ja) * 2000-07-13 2011-03-02 株式会社資生堂 ゲル組成物及び美爪料
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US8216609B2 (en) * 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
EP1689367A1 (en) * 2003-10-21 2006-08-16 Actavis Group HF Pharmaceutical formulations containing quetiapine

Also Published As

Publication number Publication date
KR20070102563A (ko) 2007-10-18
AU2006209212B2 (en) 2011-02-17
US20080268043A1 (en) 2008-10-30
CN101124209A (zh) 2008-02-13
EA200701591A1 (ru) 2008-02-28
CA2595885A1 (en) 2006-08-03
JP2008528607A (ja) 2008-07-31
AU2006209212A1 (en) 2006-08-03
IL184768A0 (en) 2007-12-03
ZA200706068B (en) 2008-11-26
MX2007008985A (es) 2007-12-06
WO2006081347A3 (en) 2006-12-28
BRPI0606932A2 (pt) 2009-07-28
WO2006081347A2 (en) 2006-08-03
EP1846382A2 (en) 2007-10-24
WO2006081347B1 (en) 2007-02-22

Similar Documents

Publication Publication Date Title
NO20073065L (no) Injiserbare nanopartikulaere olanzapinformuleringer
UA86042C2 (en) Substituted indazole-o-glucosides
WO2006099373A3 (en) Cell scaffold matrices with image contras agents
IL233634A0 (en) Methods, compositions and kits for treating medical conditions
DE60330181D1 (de) Actriib-fusionspolypeptide und verwendungen dafür
WO2006089023A3 (en) Pharmaceutical compositions for treating or preventing bone conditions
WO2010030714A8 (en) Platelet-derived growth factor compositions and methods for the treatment of tendon and ligament injuries
WO2007092622A3 (en) Compositions and methods for treating bone
BRPI0608453A2 (pt) compostos tendo atividade na correção de processamento de cftr mutante e usos destes
WO2005086860A3 (en) Methods for generating insulin-producing cells
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
DK2207786T3 (da) 2´-Fluor-2´-deoxytetrahydrouridiner som cytidindeaminasehæmmere
WO2011020120A3 (en) Multi-transgenic pigs for diabetes treatment
BRPI0413234A (pt) derivados de imidazola bicìclica contra flaviviridae
PL376409A1 (en) Composition for the treatment of infection by flaviviridae viruses
WO2005091853A3 (en) Methods and compositions for treating il-13 related pathologies
NO20092073L (no) Modulatorer av C3A-reseptor, og fremgangsmater for anvendelse derav
CY1108196T1 (el) Αντιμικροβιακες φαρμακευτικες συνθεσεις χορηγουμενες απο το στομα
WO2007042271A3 (en) Nutraceutical composition for the treatment of muscle wasting
BRPI0509262A (pt) combinação de herbicidas
NO20074313L (no) Preparater for kontrollert frigjoring omfattende et antipsykotisk middel
WO2007081878A8 (en) Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
MX2008000104A (es) Composiciones y metodos para alterar el color de los dientes.
TW200716088A (en) Formulations and methods for treating amyloidosis
CL2013000709A1 (es) Composicion que contiene nifurtimox y un antihelmintico seleccionado de: pf1022, emopdepsido, tribendimidina, amidantel, bay d 9216, praziquantel o benzoato de bencilo; util en el tratamiento de enfermedades causadas por giardias (div. sol. 1577-10).

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application